[Federal Register Volume 74, Number 196 (Tuesday, October 13, 2009)]
[Notices]
[Pages 52492-52493]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-24522]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-10-0612]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 
and send comments to Maryam Daneshvar, CDC Acting Reports Clearance 
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail 
to <a href="/cdn-cgi/l/email-protection#cea1a3ac8eadaaade0a9a1b8"><span class="__cf_email__" data-cfemail="7b1416193b181f18551c140d">[email protected]</span></a>.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Well-Integrated Screening and Evaluation for Women Across the 
Nation (WISEWOMAN) Reporting System (OMB <greek-i>0920-0612, exp. 1/31/
2010)--Revision--National Center

[[Page 52493]]

for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers 
for Disease Control and Prevention (CDC).

Background and Brief Description

    Cardiovascular disease (CVD), which includes heart disease, 
myocardial infarction, and stroke, is the leading cause of death for 
women in the United States, and is largely preventable. The WISEWOMAN 
program (Well-Integrated Screening and Evaluation for Women Across the 
Nation), administered by the Centers for Disease Control and Prevention 
(CDC), was established to examine ways to improve the delivery of 
services for women who have limited access to health care and elevated 
risk factors for CVD. The program focuses on reducing CVD risk factors 
and provides screening services for select risk factors such as 
elevated blood cholesterol, hypertension and abnormal blood glucose 
levels. The program also provides lifestyle interventions and medical 
referrals. On an annual basis, 15 grantees funded through the WISEWOMAN 
program have provided services to approximately 30,000 women who are 
already participating in the National Breast and Cervical Cancer Early 
Detection Program (NBCCEDP), also administered by CDC. CDC plans to 
increase the reach of the WISEWOMAN program by increasing the number of 
grantees from 15 to 21.
    CDC currently collects information from WISEWOMAN grantees to 
support continuous program monitoring and improvement activities. CDC 
seeks to extend OMB approval for three additional years. The total 
estimated annualized burden will increase due to the increase in the 
number of funded grantees. However, the burden to each respondent will 
decrease due to a reduction in the frequency of data collection for 
items that were previously collected on a quarterly basis. During the 
next OMB approval period, all information will be collected twice per 
year.
    Information reported to CDC includes baseline and follow-up data 
(12 months post enrollment) for all women served through the WISEWOMAN 
program. These data, called the minimum data elements (MDE), include 
data elements that describe risk factors for the women served in each 
program and data elements that describe the number and type of 
intervention sessions attended. Funded grantees compile the data from 
their existing databases and report the MDE to CDC in April and October 
of each year. The MDE data provide an assessment of how effective the 
WISEWOMAN program is at reducing the burden of cardiovascular disease 
risk factors among women who utilize program services. The information 
collected from grantees is also used to assess the cost-effectiveness 
and impact of the program. The overall program evaluation is designed 
to demonstrate how WISEWOMAN can obtain more complete health data on 
vulnerable populations, promote public education about disease 
incidence and risk-factors, improve the availability of screening and 
diagnostic services for under-served women, ensure the quality of 
services provided to under-served women, and develop strategies for 
improved interventions. The information reported to CDC also includes 
programmatic information related to grantee management, public 
education and outreach, professional education, service delivery, cost, 
and progress toward meeting stated programmatic objectives.
    All MDE information will be submitted to CDC electronically. 
Progress reports will be submitted in hardcopy format. Because certain 
demographic information has already been collected as part of NBCCEDP, 
the additional burden on grantees will be modest. There is no cost to 
the respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of  respondent           Form name       respondents    responses per   response (in     (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
WISEWOMAN Grantees............  WISEWOMAN MDEs..              21               2              40           1,680
                                Progress Report.              21               2              16             672
----------------------------------------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           2,352
----------------------------------------------------------------------------------------------------------------


    Dated: October 5, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E9-24522 Filed 10-9-09; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>